Pubblicazioni

The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity

2023 - CANCER IMMUNOLOGY, IMMUNOTHERAPY

Girone, Carlo; Calati, Federica; Lo Cigno, Irene; Salvi, Valentina; Tassinari, Valentina; Schioppa, Tiziana; Borgogna, Cinzia; LOSPINOSO SEVERINI, Ludovica; Hiscott, John; Cerboni, Cristina; Soriani, Alessandra; Bosisio, Daniela; Gariglio, Marisa

The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide

2020 - CANCER IMMUNOLOGY, IMMUNOTHERAPY

Sarkar, Subhashis; Chauhan, Sachin K S; Daly, John; Natoni, Alessandro; Fairfield, Heather; Henderson, Robert; Nolan, Emma; Swan, Dawn; Hu, Jinsong; Reagan, Michaela R; O'Dwyer, Michael

Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias

2016 - CANCER IMMUNOLOGY, IMMUNOTHERAPY

Pietra, G.; Vitale, C.; Pende, D.; Bertaina, A.; Moretta, F.; Falco, M.; Vacca, P.; Montaldo, E.; Cantoni, C.; Mingari, M. C.; Moretta, A.; Locatelli, F.; Moretta, L.